APA (7th ed.) Citation

T, G., N, V., K, K., A, W., K, K., G, S., . . . S, P. (2013). Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma. Cancer immunology, immunotherapy : CII, 62(6), 1083. https://doi.org/10.1007/s00262-013-1407-9

Chicago Style (17th ed.) Citation

T, Ghansah, Vohra N, Kinney K, Weber A, Kodumudi K, Springett G, Sarnaik AA, and Pilon-Thomas S. "Dendritic Cell Immunotherapy Combined with Gemcitabine Chemotherapy Enhances Survival in a Murine Model of Pancreatic Carcinoma." Cancer Immunology, Immunotherapy : CII 62, no. 6 (2013): 1083. https://doi.org/10.1007/s00262-013-1407-9.

MLA (9th ed.) Citation

T, Ghansah, et al. "Dendritic Cell Immunotherapy Combined with Gemcitabine Chemotherapy Enhances Survival in a Murine Model of Pancreatic Carcinoma." Cancer Immunology, Immunotherapy : CII, vol. 62, no. 6, 2013, p. 1083, https://doi.org/10.1007/s00262-013-1407-9.